Department of Clinical and Experimental Cardiology, Academic Medical Center, University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Circ Res. 2011 Apr 1;108(7):884-97. doi: 10.1161/CIRCRESAHA.110.238469.
Variations in the gene encoding for the major sodium channel (Na(v)1.5) in the heart, SCN5A, has been shown to cause a number of arrhythmia syndromes (with or without structural changes in the myocardium), including the long-QT syndrome (type 3), Brugada syndrome, (progressive) cardiac conduction disease, sinus node dysfunction, atrial fibrillation, atrial standstill, and dilated cardiomyopathy. Of equal importance are variations in genes encoding for various subunits and regulatory proteins interacting with the α-subunit Na(v)1.5 and modifying its function. Based on detailed studies of genotype-phenotype relationships in these disease entities, on detailed studies of the basic electrophysiological phenotypes (heterologous expressed wild-type and mutant sodium channels and their interacting proteins), and on attempts to integrate the obtained knowledge, the past 15 years has witnessed an explosion of knowledge about these disease entities.
心脏中主要钠离子通道(Na(v)1.5)编码基因的变异已被证明可引起多种心律失常综合征(伴或不伴心肌结构改变),包括长 QT 综合征(3 型)、Brugada 综合征、(进行性)心脏传导疾病、窦房结功能障碍、心房颤动、心房停搏和扩张型心肌病。同样重要的是,与α亚单位 Na(v)1.5相互作用并修饰其功能的各种亚单位和调节蛋白的编码基因的变异。基于这些疾病实体中基因型-表型关系的详细研究、对基本电生理表型(异源表达的野生型和突变型钠离子通道及其相互作用蛋白)的详细研究,以及整合所获得知识的尝试,过去 15 年见证了这些疾病实体的知识爆发。